EUCTR2016-004551-67-DE进行中（未招募）1 期
A randomised, controlled, open-label study to confirm the efficacy and safety of sedation with isoflurane in invasively ventilated ICU patients using the AnaConDa administration system
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Male or female subjects, >= 18 years
- •2.Continuous invasive ventilation and sedation <= 48 hours at start of study sedation
- •3.Clinically likely to need invasive ventilation and sedation >= 24 hours at randomisation
- •4.Ongoing sedation with propofol at time of randomisation
- •5.Prescribed target sedation depth within the RASS range -1 to -4
- •6.Signed informed consent or emergency situation inclusion criteria fulfilled and documented, according to procedure described in section 9.4
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 465
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 85
排除标准
- •1.Has not reached prescribed target sedation depth any time within the last 8 hours at randomisation
- •2.History of or genetic predisposal for malignant hyperthermia
- •3.Uncompensated acute circulatory failure at time of randomisation (MAP < 55 mmHg despite iv fluids and vasopressors).
- •4.Hepatic impairment of classification C according to the Child-Pugh score (Cholongitas et al., 2005).
- •5.Any for the study relevant clinically significant abnormalities in clinical chemistry or haematology results at the time of screening , precluding study participation as judged by the investigator
- •6.Acute neuropathology without ICP monitoring, including but not limited to stroke, neurosurgery and head trauma.
- •7.Planned anaesthesia or surgery within 24 hours from randomisation
- •8.Tidal volume < 350 ml
- •9.History of any clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or influence the results or the subject’s ability to participate in the study
- •10.Need for continuous muscle relaxation at the time of randomisation
- •11.Positive pregnancy test in women
- •12.History of allergy/hypersensitivity to isoflurane or propofol
- •13.Known participation in any other clinical study that included drug treatment within three months of the first administration of investigational product
- •14.Documented limitation of medical treatment.
研究者
相似试验
进行中（未招募）
1 期
A randomised, controlled, open-label study to confirm the efficacy and safety of sedation with isoflurane in invasively ventilated ICU patients using the AnaConDa administration systemEUCTR2016-004551-67-SISedana Medical AB300
招募中
2 期
An open-label, randomized controlled study evaluating the effectiveness of Pramipexole extended-release tablets for tardive dystonia patientsTardive dystoniaDrug-induced extrapyramidal syndromeG240JPRN-jRCTs031180316Iyo Masaomi24
招募中
2 期
An open-label, randomized controlled study evaluating the effectiveness of pramipexole extended-release tablets for tardive dystonia.Tardive dystoniaJPRN-UMIN000014988Department of Psychiatry, Chiba University Graduate School of Medicine24
招募中
4 期
Postoperative comparison of Sterizone® dressing versus standard gauze dressing in women having cesarean sectioCTRI/2022/10/046881Dynamic Techno Medicals Private Limited
进行中（未招募）
1 期
An open label randomised controlled study to evaluate the induction of immune memory following infant vaccination with a glyco-conjugate Neisseria meningitidis serogroup C vaccine and to assess the immunological impact of administering routine infant immunisations in consistent versus alternating limbs - Can we reduce the number of vaccine injections for children?Active immunisation of children for the prevention of invasive diseases caused by Neisseria meningitidis serogroup C, Streptococcus pneumoniae, diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by Haemophilus influenzae type b.MedDRA version: 12.0 Level: LLT Classification code 10028911 Term: Neisseria meningitidis infection NOSMedDRA version: 12.1 Level: LLT Classification code 10042194 Term: Streptococcus pneumoniae meningitisMedDRA version: 12.1 Level: LLT Classification code 10042195 Term: Streptococcus pneumoniae pneumoniaMedDRA version: 12.1 Level: LLT Classification code 10035648 Term: Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]MedDRA version: 12.1 Level: LLT Classification code 10042197 Term: Streptococcus pneumoniae septicaemiaMedDRA version: 12.1 Level: LLT Classification code 10018952 Term: Haemophilus influenzae infectionMedDRA version: 12.1 Level: LLT Classification code 10018953 Term: Haemophilus influenzae meningitisMedDRA version: 12.1 Level: LLT Classification code 10035680 Term: Pneumonia due to Haemophilus influenzae (H. influenzae)MedDRA version: 12.1 Level: LLT Classification code 10058214 Term: Septicaemia due to haemophilus influenzae (H. influenzae)EUCTR2009-016579-31-GBniversity of Oxford509